TABLE 1.

Overview of the cancer type and stage‐specific data used for estimating the impact in terms of survival and 5‐year healthcare costs, with TNM classification and relative survival probabilities for breast, colorectal, and lung cancer, and T‐stage classification and overall survival probabilities for melanoma

	Breast Cancer	Colorectal Cancer	Lung Cancer	Melanoma
Predicted incidence for 2020 (#)	19 998	16 634	13 092	15 691
Stage at Treatment Initiation (%)
stage I / T1	43.0	22.1	11.7	61.8
stage II / T2	34.7	24.3	6.5	13.6
stage III / T3	12.1	23.6	11.2	10.2
stage IV / T4	4.6	17.7	42.2	6.6
stage unknown	5.5	12.3	28.5	7.8
1‐year survival (%)
stage I / T1	100.0	99.3	90.8	99.2
stage II / T2	99.9	96.4	69.8	98.0
stage III / T3	98.1	93.5	57.8	97.2
stage IV / T4	69.2	49.3	19.2	94.8
stage unknown	89.5	75.9	43.6	89.9
2‐year survival (%)
stage I / T1	100.0	99.1	82.7	97.9
stage II / T2	98.8	94.2	52.4	94.5
stage III / T3	93.4	85.5	32.9	89.5
stage IV / T4	57.6	32.0	8.3	65.0
stage unknown	83.1	65.8	27.1	80.7
3‐year survival (%)
stage I / T1	100.0	98.8	76.1	96.9
stage II / T2	97.5	92.9	42.0	89.6
stage III / T3	88.3	79.1	25.2	83.9
stage IV / T4	47.1	22.8	5.3	75.5
stage unknown	76.4	61.4	20.4	76.3
4‐year survival (%)
stage I / T1	100.0	99.0	71.4	94.4
stage II / T2	95.7	90.8	35.6	85.8
stage III / T3	84.2	74.3	20.1	78.8
stage IV / T4	38.7	16.8	3.9	67.5
stage unknown	69.9	58.7	16.1	74.6
5‐year survival (%)
stage I / T1	100.0	98.6	67.7	91.7
stage II / T2	94.6	88.6	32.3	83.0
stage III / T3	80.6	71.3	17.1	73.2
stage IV / T4	32.0	13.4	3.2	61.6
stage unknown	65.0	56.9	14.4	73.7
Healthcare costs over 5 years
stage I / T1	$50,699	$51,531	$28,532	$13,981
stage II / T2	$67,069	$66,504	$28,532	$25,715
stage III / T3	$98,632	$121,558	$67,065	$30,644
stage IV / T4	$105,934	$120,015	$79,045	$38,216
stage unknown	$100,860	$121,077	$70,678	$32,960